ABCG8 D19H - GET-Evidence

Note: This variant has not been sufficiently evaluated by a GET-Evidence editor.

To be considered sufficiently evaluated a variant must have both "variant evidence" and "clinical importance" scores filled in.

Please help improve GET-Evidence by evaluating evidence for this variant!


(See the latest version)


(ABCG8 Asp19His)

You are viewing an old version of this page that was saved on January 5, 2010 at 10:42pm by OMIM Importing Robot.

Edited in this revision:

Short summary


Variant evidence
Computational -
Functional -
Case/Control -
Familial -
Clinical importance
Severity -
Treatability -
Penetrance -


Insufficiently evaluated pathogenic

(The "insufficiently evaluated" qualifier is assigned automatically based on the above evidence and importance scores.)

Inheritance pattern


Summary of published research, and additional commentary


Allele frequency

  • C @ chr2:44066247: 5.8% (531/9216) in EVS
  • C @ chr2:43919750: 11.7% (15/128) in GET-Evidence
  • Frequency shown in summary reports: 5.8% (531/9216)



Other external references

  • Gallstones (rs11887534-C)
    Buch 15-Jul-07 in Nat Genet
    OR or beta: 2.2 [1.80-2.60]
    Risk allele frequency: 0.10
    p-value: 1.00E-14
    Initial sample: 280 cases, 360 controls
    Replication sample: 2,000 cases, 1,202 controls
  • [Cholelithiasis]
    In a GWAS of cases and controls from an unspecificied population, rs11887534 was found to be associated with gallstones. This finding was replicated in German and Chilean populations.
  • [Cholelithiasis]
    GWAS Results: A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease (Initial Sample Size: 280 cases, 360 controls; Replication Sample Size: 2,000 cases, 1,202 controls; Risk Allele: rs11887534-C).; Web Resource:
  • Score: 0 (benign)

Other in silico analyses

  • NBLOSUM100 score = 3
  • GET-Evidence autoscore = 3

Edit history

Gene search

"GENE" or "GENE A123C":

Log in